Skip to main content

ExodusPoint Capital Management, LP

Position in LLY — ELI LILLY & Co

CIK 1736225 NEW YORK, NY

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,358,152
-$6,279,017 QoQ
Shares Held
14,472
-43.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#958
of 4,605 holders
Holding Since
Jun 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Sep 30, 2024
CallValue
$354,376
CallShares
400
PutValue
$354,376
PutShares
400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $41,945,321 across 5 Drug Manufacturers - General names. LLY ranks #1 (41.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page
14,472 $17,358,152

All Filings in LLY

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,358,152 14,472
2026-03-31 $23,637,169 25,699
2025-06-30 $18,380,537 23,579
2024-09-30 $354,376 400
2024-09-30 $12,655,652 14,285
2024-09-30 $354,376 400
2024-06-30 $3,802,596 4,200
2024-06-30 $3,802,596 4,200
2024-06-30 $25,372,369 28,024
2024-03-31 $7,624,008 9,800
2024-03-31 $6,223,680 8,000
2023-12-31 $124,278,544 213,200
2023-12-31 $7,856,595 13,478
2023-09-30 $23,304,996 43,388
2022-09-30 $16,006,148 49,501
2022-06-30 $28,192,771 86,953
2021-12-31 $7,618,700 27,582
2021-09-30 $2,515,672 10,888
2021-06-30 $4,681,978 20,399
2021-03-31 $6,563,920 35,135
2020-09-30 $21,710,389 146,672
2020-06-30 $5,211,073 31,740